Suppr超能文献

肿瘤微环境中趋化因子表达的调控

Regulation of chemokine expression in the tumor microenvironment.

作者信息

Gorbachev Anton V, Fairchild Robert L

机构信息

Department of Immunology, Cleveland Clinic, Cleveland, OH, 44195.

Department of Immunology and Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 and Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106.

出版信息

Crit Rev Immunol. 2014;34(2):103-20. doi: 10.1615/critrevimmunol.2014010062.

Abstract

Chemokines are chemotactic cytokines critical for homeostatic and inflammation-induced trafficking of leukocytes during immune responses, hematopoesis, wound healing, and tumorigenesis. Despite three decades of intensive study of the chemokine network, the molecular mechanisms regulating chemokine expression during tumor growth are not well understood. In this review, we focus on the role of chemokines in both tumor growth and anti-tumor immune responses and on molecular mechanisms employed by tumor cells to regulate chemokine expression in the tumor microenvironment. Multiple mechanisms used by tumors to regulate chemokine production, including those revealed by very recent studies (such as DNA methylation or post-translational nitrosylation of chemokines) are discussed. Concluding the review, we discuss how understanding of these regulatory mechanisms can be used in cancer therapy to suppress tumor growth and/or to promote immune-mediated eradication of tumors.

摘要

趋化因子是一类趋化性细胞因子,在免疫反应、造血、伤口愈合和肿瘤发生过程中,对白细胞的稳态和炎症诱导的运输至关重要。尽管对趋化因子网络进行了三十年的深入研究,但在肿瘤生长过程中调节趋化因子表达的分子机制仍未得到充分理解。在这篇综述中,我们重点关注趋化因子在肿瘤生长和抗肿瘤免疫反应中的作用,以及肿瘤细胞在肿瘤微环境中调节趋化因子表达所采用的分子机制。我们讨论了肿瘤用于调节趋化因子产生的多种机制,包括最近的研究揭示的机制(如趋化因子的DNA甲基化或翻译后亚硝化)。在综述结尾,我们讨论了如何利用对这些调节机制的理解来进行癌症治疗,以抑制肿瘤生长和/或促进免疫介导的肿瘤根除。

相似文献

1
Regulation of chemokine expression in the tumor microenvironment.肿瘤微环境中趋化因子表达的调控
Crit Rev Immunol. 2014;34(2):103-20. doi: 10.1615/critrevimmunol.2014010062.
3
Chemokines and the immune response to cancer.趋化因子与癌症的免疫反应。
Immunity. 2021 May 11;54(5):859-874. doi: 10.1016/j.immuni.2021.01.012. Epub 2021 Apr 10.
5
Chemokines in cancer.趋化因子与癌症。
Cancer Immunol Res. 2014 Dec;2(12):1125-31. doi: 10.1158/2326-6066.CIR-14-0160.
10
Inflammatory chemokines and metastasis--tracing the accessory.炎症趋化因子与转移——追踪辅助因素。
Oncogene. 2014 Jun 19;33(25):3217-24. doi: 10.1038/onc.2013.272. Epub 2013 Jul 15.

引用本文的文献

8
Role of CC-chemokine ligand 2 in gynecological cancer.CC趋化因子配体2在妇科癌症中的作用
Cancer Cell Int. 2022 Nov 19;22(1):361. doi: 10.1186/s12935-022-02763-z.

本文引用的文献

1
CXCR3, a double-edged sword in tumor progression and angiogenesis.CXCR3,肿瘤进展和血管生成中的一把双刃剑。
Biochim Biophys Acta. 2013 Dec;1836(2):287-95. doi: 10.1016/j.bbcan.2013.08.002. Epub 2013 Aug 27.
9
The pros and cons of chemokines in tumor immunology.趋化因子在肿瘤免疫学中的利弊。
Trends Immunol. 2012 Oct;33(10):496-504. doi: 10.1016/j.it.2012.05.007. Epub 2012 Jun 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验